These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 36338972)

  • 1. Combining bulk RNA-sequencing and single-cell RNA-sequencing data to reveal the immune microenvironment and metabolic pattern of osteosarcoma.
    Huang R; Wang X; Yin X; Zhou Y; Sun J; Yin Z; Zhu Z
    Front Genet; 2022; 13():976990. PubMed ID: 36338972
    [No Abstract]   [Full Text] [Related]  

  • 2. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model.
    Tan Z; Chen X; Zuo J; Fu S; Wang H; Wang J
    J Transl Med; 2023 Mar; 21(1):223. PubMed ID: 36973787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studying the mechanism underlying lipid metabolism in osteosarcoma based on transcriptomic RNA sequencing and single-cell data.
    Li Z; Jin C; Lu X; Zhang Y; Zhang Y; Wen J; Liu Y; Liu X; Li J
    J Gene Med; 2023 Jun; 25(6):e3491. PubMed ID: 36847293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCR4 Expressed by Tumor-Infiltrating B Cells in Gastric Cancer Related to Survival in the Tumor Microenvironment: An Analysis Combining Single-Cell RNA Sequencing with Bulk RNA Sequencing.
    Su C; Yu R; Hong X; Zhang P; Guo Y; Cai JC; Hou J
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deciphering the heterogeneity and immunosuppressive function of regulatory T cells in osteosarcoma using single-cell RNA transcriptome.
    Cheng D; Zhang Z; Mi Z; Tao W; Liu D; Fu J; Fan H
    Comput Biol Med; 2023 Oct; 165():107417. PubMed ID: 37669584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic heterogeneity in early-stage lung adenocarcinoma revealed by RNA-seq and scRNA-seq.
    Zhang Y; Shi J; Luo J; Liu C; Zhu L
    Clin Transl Oncol; 2023 Jun; 25(6):1844-1855. PubMed ID: 36692643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating Bulk and Single-Cell RNA Sequencing Reveals Heterogeneity, Tumor Microenvironment, and Immunotherapeutic Efficacy Based on Sialylation-Related Genes in Bladder Cancer.
    Tan Z; Chen X; Zuo J; Fu S; Wang J; Wang H
    J Inflamm Res; 2023; 16():3399-3417. PubMed ID: 37600224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of scRNA-Seq and Bulk RNA-Seq to Analyse the Heterogeneity of Ovarian Cancer Immune Cells and Establish a Molecular Risk Model.
    Liang L; Yu J; Li J; Li N; Liu J; Xiu L; Zeng J; Wang T; Wu L
    Front Oncol; 2021; 11():711020. PubMed ID: 34621670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated transcriptomic analysis systematically reveals the heterogeneity and molecular characterization of cancer-associated fibroblasts in osteosarcoma.
    Liu Y; Han X; Han Y; Bi J; Wu Y; Xiang D; Zhang Y; Bi W; Xu M; Li J
    Gene; 2024 May; 907():148286. PubMed ID: 38367852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a Chemoresistant Risk Scoring Model for Prechemotherapy Osteosarcoma Using Single-Cell Sequencing.
    Zeng Z; Li W; Zhang D; Zhang C; Jiang X; Guo R; Wang Z; Yang C; Yan H; Zhang Z; Wang Q; Huang R; Zhao Q; Li B; Hu X; Gao L
    Front Oncol; 2022; 12():893282. PubMed ID: 35664733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of scRNA-seq and bulk RNA-seq demonstrates the effects of EVI2B or CD361 on CD8
    Xie T; Feng W; He M; Zhan X; Liao S; He J; Qin Z; Li F; Xu J; Liu Y; Wei Q
    Exp Biol Med (Maywood); 2023 Jan; 248(2):130-145. PubMed ID: 36511103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the Role of Neutrophil-Related Genes in Osteosarcoma via an Integrative Analysis of Single-Cell and Bulk Transcriptome.
    Lu J; Rui J; Xu XY; Shen JK
    Biomedicines; 2024 Jul; 12(7):. PubMed ID: 39062086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining single-cell sequencing and spatial transcriptome sequencing to identify exosome-related features of glioblastoma and constructing a prognostic model to identify BARD1 as a potential therapeutic target for GBM patients.
    Zhao S; Wang Q; Ni K; Zhang P; Liu Y; Xie J; Ji W; Cheng C; Zhou Q
    Front Immunol; 2023; 14():1263329. PubMed ID: 37727789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of bulk RNA sequencing data and single-cell RNA sequencing analysis on the heterogeneity in patients with colorectal cancer.
    Zhang J; Wu Y; Shen Z
    Funct Integr Genomics; 2023 Jun; 23(3):209. PubMed ID: 37355491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of Bulk RNA Sequencing and Single-Cell RNA Sequencing to Reveal Uveal Melanoma Tumor Heterogeneity and Cells Related to Survival.
    Gao G; Deng A; Liang S; Liu S; Fu X; Zhao X; Yu Z
    Front Immunol; 2022; 13():898925. PubMed ID: 35865532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of single-cell RNA sequencing and bulk RNA sequencing to reveal an immunogenic cell death-related 5-gene panel as a prognostic model for osteosarcoma.
    Yang J; Zhang J; Na S; Wang Z; Li H; Su Y; Ji L; Tang X; Yang J; Xu L
    Front Immunol; 2022; 13():994034. PubMed ID: 36225939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of single-cell RNA-sequencing data identifies a hypoxic tumor subpopulation associated with poor prognosis in triple-negative breast cancer.
    Shi Y; Huang X; Du Z; Tan J
    Math Biosci Eng; 2022 Apr; 19(6):5793-5812. PubMed ID: 35603379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-Cell Transcriptomics Reveals the Complexity of the Tumor Microenvironment of Treatment-Naive Osteosarcoma.
    Liu Y; Feng W; Dai Y; Bao M; Yuan Z; He M; Qin Z; Liao S; He J; Huang Q; Yu Z; Zeng Y; Guo B; Huang R; Yang R; Jiang Y; Liao J; Xiao Z; Zhan X; Lin C; Xu J; Ye Y; Ma J; Wei Q; Mo Z
    Front Oncol; 2021; 11():709210. PubMed ID: 34367994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian cancer-specific dysregulated genes with prognostic significance: scRNA-Seq with bulk RNA-Seq data and experimental validation.
    Liu C; Zhang Y; Li X; Wang D
    Ann N Y Acad Sci; 2022 Jun; 1512(1):154-173. PubMed ID: 35247207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of therapeutic targets for osteosarcoma by integrating single-cell RNA sequencing and network pharmacology.
    Wang Y; Qin D; Gao Y; Zhang Y; Liu Y; Huang L
    Front Pharmacol; 2022; 13():1098800. PubMed ID: 36686663
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.